Truant S, El Amrani M, Baillet C, Ploquin A, Lecolle K, Ernst O, Hebbar M, Huglo Damien; Pruvot François-René

Language: English
References: 10
Page: 269-273
PDF size: 172.16 Kb.

ABSTRACT

Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) has emerged as an alternative for patients with bilobar colorectal liver metastasis deemed unresectable due to inadequate future remnant liver (FRL). Nevertheless, high morbidity and mortality rates have been reported. In this setting, including hepatobiliary scintigraphy in the clinical and surgical management of patients offered ALPPS has been advocated to both assess eligibility for ALPPS stage1 and suitable time for ALPPS stage2. Recently, it was stated that partial ALPPS with a liver split restricted to 50% of the transection line (or up to the middle hepatic vein in case of right extended hepatectomy) and a shortened stage1 allows improving the postoperative course without precluding the inter-stages FRL hypertrophy. We describe a case series of p-ALPPS with stage1 performed laparoscopically, including sequential assessments of the FRL volumes and functions via pre-stage1 and pre-stage2 computed tomography volumetry and HIDA SPECT-scintigraphy. In five patients, laparoscopic p-ALPPS was associated with rapid and significant gain of remnant functional volume - much better than previously observed for ALPPS - facilitating early stage2 without inflammatory adherences. In conclusion, laparoscopic p-ALPPS is feasible and seems less aggressive than the original ALPPS technique with total transection. It may be an interesting alternative to the classical portal vein embolization (PVE) and two-stage hepatectomy strategy.

REFERENCES

1. Truant S, Baillet C, Deshorgue AC, Leteurtre E, Hebbar M, Ernst O, Huglo D, et al. Drop of Total Liver Function in the Interstages of the New Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Technique: Analysis of the Auxiliary Liver by HIDA Scintigraphy. Ann Surg 2016; 263: e33-4.

2. Truant S, Scatton O, Dokmak S, Regimbeau JM, Lucidi V, Laurent A, Gauzolino R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Impact of the inter-stages course on morbi-mortality and implications for management. Eur J Surg Oncol 2015; 41: 674-82.

3. Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, Abdalla EK, et al. Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry. Ann Surg 2015; 262: 780-6.

4. Truant S, Baillet C, Deshorgue AC, El Amrani M, Huglo D, Pruvot F-R. Contribution of hepatobiliary scintigraphy in assessing ALPPS most suited timing. Updates Surg 2017; 69: 411-9.

5. Olthof PB, Tomassini F, Huespe PE, Truant S, Pruvot F-R, Troisi RI, Castro C, et al. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function. Surgery 2017; 162: 775-83.

6. Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, Soubrane O, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg 2014; 260: 828-9.

7. Truant S, Pruvot F-R. Is there still a room to improve the safety of ALPPS procedure? A new technical note. Eur J Surg Oncol 2015; 41: 1554-5.

8. de Santibanes E, Alvarez FA, Ardiles V, Pekolj J, de Santibanes M. Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique. Langenbecks Arch Surg 2016; 401: 557-63.

9. de Graaf W, van Lienden KP, Dinant S, Roelofs JJ, Busch OR, Gouma DJ, Bennink RJ, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 2010; 14: 369-78.

10. Levi Sandri GB, Vennarecci G, Ettorre GM. ALPPS in Setting Minimally Invasive Surgery for Hepatocellular Carcinoma. Ann Surg 2017; 266: e66-7.